ResMed, a global leader in digital health, is now distributing the onesleeptest by Ectosense in India to help patients and physicians diagnose millions of Indians who suffer from undiagnosed sleep apnea.

onesleeptest by Ectosense is a disposable, multi-night use test based on peripheral arterial tonometry technology with a built-in NightOwl sensor (driven by Photoplethysmography-PPG technology) to measure key indicators such as heart rate, oxygen desaturation and body movements to determine sleep quality. The onesleeptest device accurately tracks and delivers results by a certified sleep specialist within 3-5 working days, making it an ideal solution to test sleep quality from the comfort and safety of your home during the pandemic.

ResMed is launching a three-part ‘onesleeptest’ service in conjunction with World Sleep Day (March 19), includes the home sleep test, along with sleep scoring by a leading sleep physician in India and sleep coach consultancy to support patients’ journey from diagnosis to therapy. 

“Home sleep tests are reliable, comfortable and are even recommended by the American Society of Sleep Medicine,” said Seema Arora, Marketing Manager, Asia & LatAm – ANZ, ResMed. “We believe home sleep tests are essential to helping diagnose more people who suffer from sleep apnea, especially at a time when social distancing and contactless diagnosis is encouraged.”

ResMed has partnered with Indian stand-up comedian, writer, presenter, and actor Jeeveshu Ahluwalia, who himself is a sleep apnea patient with type 2 diabetes and obesity to underline the need for testing and importance of sleep quality.  

onesleeptest allows a patient to assess their results via email by a certified sleep specialist at ResMed, along with suitable therapies and treatments.